Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Predictors for fatal human infections with avian H7N9 influenza, evidence from four epidemic waves in Jiangsu Province, Eastern China, 2013-2016.

Ma W, Huang H, Chen J, Xu K, Dai Q, Yu H, Deng F, Qi X, Wang S, Hong J, Bao C, Huo X, Zhou M.

Influenza Other Respir Viruses. 2017 Sep;11(5):418-424. doi: 10.1111/irv.12461. Epub 2017 Jul 26.

2.

Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?

Hulme KD, Gallo LA, Short KR.

Front Microbiol. 2017 May 22;8:861. doi: 10.3389/fmicb.2017.00861. eCollection 2017.

3.

Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia.

Li H, Yang SG, Gu L, Zhang Y, Yan XX, Liang ZA, Zhang W, Jia HY, Chen W, Liu M, Yu KJ, Xue CX, Hu K, Zou Q, Li LJ, Cao B, Wang C; National Influenza A(H1N1)pdm09 Clinical Investigation Group of China.

Influenza Other Respir Viruses. 2017 Jul;11(4):345-354. doi: 10.1111/irv.12456. Epub 2017 Jun 9.

4.

Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis.

Badawi A, Ryoo SG.

J Public Health Res. 2016 Dec 21;5(3):733. doi: 10.4081/jphr.2016.733. eCollection 2016 Dec 9.

5.

Corticosteroids for severe influenza pneumonia: A critical appraisal.

Nedel WL, Nora DG, Salluh JI, Lisboa T, Póvoa P.

World J Crit Care Med. 2016 Feb 4;5(1):89-95. doi: 10.5492/wjccm.v5.i1.89. eCollection 2016 Feb 4. Review.

6.

Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Zhang Y, Sun W, Svendsen ER, Tang S, MacIntyre RC, Yang P, Zhang D, Wang Q.

Crit Care. 2015 Feb 20;19:46. doi: 10.1186/s13054-015-0764-5.

7.

Thin-section computed tomography detects long-term pulmonary sequelae 3 years after novel influenza A virus-associated pneumonia.

Xing ZH, Sun X, Xu L, Wu Q, Li L, Wu XJ, Shao XG, Zhao XQ, Wang JH, Ma LY, Wang K.

Chin Med J (Engl). 2015 Apr 5;128(7):902-8. doi: 10.4103/0366-6999.154285.

8.

Characteristics of Hospitalized Patients with Severe and Non-Severe Pandemic Influenza A (H1N1) in Saurashtra Region, India (Two Waves Analysis).

Chudasama RK, Patel UV, Verma PB.

J Family Med Prim Care. 2013 Apr;2(2):182-7. doi: 10.4103/2249-4863.117397.

9.

Predictors of mortality and length of stay in hospitalized cases of 2009 influenza A (H1N1): Experiences of a tertiary care center.

Chawla R, Kansal S, Chauhan M, Jain A, Jibhkate BN.

Indian J Crit Care Med. 2013 Sep;17(5):275-82. doi: 10.4103/0972-5229.120318.

10.

A Two Wave Analysis of Hospitalizations and Mortality from Seasonal and Pandemic 2009 A (H1N1) Influenza in Saurashtra, India: 2009-2011.

Chudasama R, Patel U, Verma P, Banerjee A, Buch P, Patel P.

Ann Med Health Sci Res. 2013 Jul;3(3):334-40. doi: 10.4103/2141-9248.117929.

11.

Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1.

Durkin ML, Marchese D, Robinson MD, Ramgopal M.

BMJ Case Rep. 2013 Sep 30;2013. pii: bcr2013200474. doi: 10.1136/bcr-2013-200474.

12.

Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.

Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M.

BMJ. 2013 Aug 23;347:f5061. doi: 10.1136/bmj.f5061. Review.

13.

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR.

PLoS One. 2012;7(9):e43491. doi: 10.1371/journal.pone.0043491. Epub 2012 Sep 11.

14.

Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.

Blumentals WA, Arreglado A, Napalkov P, Toovey S.

BMC Musculoskelet Disord. 2012 Aug 27;13:158. doi: 10.1186/1471-2474-13-158.

15.

Socioeconomic factors influencing hospitalized patients with pneumonia due to influenza A(H1N1)pdm09 in Mexico.

Manabe T, Higuera Iglesias AL, Vazquez Manriquez ME, Martinez Valadez EL, Ramos LA, Izumi S, Takasaki J, Kudo K.

PLoS One. 2012;7(7):e40529. doi: 10.1371/journal.pone.0040529. Epub 2012 Jul 11.

16.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

17.

Risk factors for severe cases of 2009 influenza A (H1N1): a case control study in Zhejiang Province, China.

Fang L, Lin J, Chai C, Yu Z.

PLoS One. 2012;7(3):e34365. doi: 10.1371/journal.pone.0034365. Epub 2012 Mar 28.

18.

Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China.

Deng LH, Zeng YL, Feng P, Liu YL, Wang LC, Bai Y, Tang H.

J Zhejiang Univ Sci B. 2012 Jan;13(1):49-55. doi: 10.1631/jzus.B1100168.

19.

Risk factors for death from pandemic (H1N1) 2009, southern Brazil.

Yokota RT, Skalinski LM, Igansi CN, de Souza LR, Iser BP, Reis PO, Barros EN, Macário EM, Bercini MA, Ranieri TM, Araújo WN.

Emerg Infect Dis. 2011 Aug;17(8):1467-71. doi: 10.3201/eid1708.101233.

20.

Laboratory diagnosis, epidemiology, and clinical outcomes of pandemic influenza A and community respiratory viral infections in southern Brazil.

Raboni SM, Stella V, Cruz CR, França JB, Moreira S, Gonçalves L, Nogueira MB, Vidal LR, Almeida SM, Debur MC, Carraro H Jr, dos Santos CN.

J Clin Microbiol. 2011 Apr;49(4):1287-93. doi: 10.1128/JCM.02205-10. Epub 2011 Jan 19.

Supplemental Content

Support Center